Thyrotoxicosis is a well-documented and studied complication of treatment with amiodarone, but little has been written about the risks and treatment of recurrent thyrotoxicosis upon re-exposure to ...

For example, despite iopanoic acid therapy for type II AIT, the thyrotoxicosis lasts on average ... [2] If, and when, amiodarone therapy should be stopped during AIT is debated.

The incidence of type 2 amiodarone-induced thyrotoxicosis (AIT) is increasing. A new study provides evidence that glucocorticoid therapy is safe, effective and associated with prompt restoration ...

Lancet 1997; 350: 1417–24. MEDLINE 2. Trip MD, Wiersinga WM, Plomp TA: Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med 1991 ...